Analytical Data
-
基因名
hly
- Application
-
别名
hly;KUZ;MADM;Disintegrin and metalloProteinase domain-containing Protein 10
-
种属
E.coli
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P09616
-
表达区间
27-319aa
-
氨基酸序列
ADSDINIKTGTTDIGSNTTVKTGDLVTYDKENGMHKKVFYSFIDDKNHNKKLLVIRTKGTIAGQYRVYSEEGANKSGLAWPSAFKVQLQLPDNEVAQISDYYPRNSIDTKEYMSTLTYGFNGNVTGDDTGKIGGLIGANVSIGHTLKYVQPDFKTILESPTDKKVGWKVIFNNMVNQNWGPYDRDSWNPVYGNQLFMKTRNGSMKAADNFLDPNKASSLLSSGFSPDFATVITMDRKASKQQTNIDVIYERVRDDYQLHWTSTNWKGTNTKDKWTDRSSERYKIDWEKEEMTN
-
分子量
33.4 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HLY, or Hemolysin, is a protein produced by certain pathogenic bacteria, such as *Vibrio cholerae*, which plays a critical role in the virulence and pathogenicity of these organisms. Research into HLY focuses on understanding its structure, function, and mechanisms of action, particularly how it interacts with host cells and contributes to bacterial invasion and immune evasion. The study of HLY is significant for several reasons: it sheds light on fundamental biological processes in bacterial pathogenesis, facilitates the development of potential diagnostic tools, and offers insights for vaccine development. Additionally, recombinant HLY proteins can be engineered for various applications, including as adjuvants in vaccines or as targets for therapeutic interventions against bacterial infections. Current research employs advanced techniques such as genetic engineering, structural biology, and immunology to explore the potential of HLY in tackling antibiotic resistance and enhancing the efficacy of existing treatments. Understanding HLY and its dynamics opens avenues for innovative approaches in infectious disease control, making it an essential focus of contemporary microbiological research.












